Nephros Inc (NEPH)

[jvg25]

my understanding is that wexford owns 50.1% of the existing shares at an average of .70 per share. now, i've thought all along that if wexford was to announce a bridge loan of, say, 2 or 3 mil, the pps would double or more. that would go a long way towards calming investors. also, neph doesn't need that much money, as i do believe the ameriwater deal will eventually make neph quite profitable(probably in a year or so), but who knows what legal costs could add up to. but, you have to wonder if wexford is really that committed to continuing with neph. the bottom line is the fda denied their 510k. if they require some expensive trials to get it passed, wexford is just as likely to decide to sell everything. wexford has something like 7 bil in assets. neph is worth about 8 mil right now. i keep imagining people at wexford saying things like, "ugh, that damn neph, i wish bill hadn't talked me into buying that". my feeling is that neph could be worth quite a bit more than it's trading for right now. they have something like 60 patents as well as CE approval for the MD220 and H2H module and the NS2000. nobody knows what will happen next, but if they can get at least 22 mil for everything(cheap), i could break even. wexford would need to sell for 30 mil(i think) to break even(which i still think could be cheap). right now that sounds good to me. otherwise, we're looking at another year of no PRs and no communication, you know, good ol' neph...GLTA